
### [MONDO:0015903](http://purl.obolibrary.org/obo/MONDO_0015903)
**Label:** hyperalphalipoproteinemia

**Subclasses:** [MONDO:0007744](http://purl.obolibrary.org/obo/MONDO_0007744) (cholesterol-ester transfer protein deficiency), [MONDO:0013533](http://purl.obolibrary.org/obo/MONDO_0013533) (hyperlipidemia due to hepatic triglyceride lipase deficiency), [MONDO:0013534](http://purl.obolibrary.org/obo/MONDO_0013534) (apolipoprotein c-Iii deficiency), 

**Mapped go classes:** [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:0046337](http://purl.obolibrary.org/obo/GO_0046337) (phosphatidylethanolamine metabolic process), [GO:0006642](http://purl.obolibrary.org/obo/GO_0006642) (triglyceride mobilization), [GO:0046461](http://purl.obolibrary.org/obo/GO_0046461) (neutral lipid catabolic process), [GO:0051005](http://purl.obolibrary.org/obo/GO_0051005) (negative regulation of lipoprotein lipase activity), [GO:0005902](http://purl.obolibrary.org/obo/GO_0005902) (microvillus), [GO:0071333](http://purl.obolibrary.org/obo/GO_0071333) (cellular response to glucose stimulus), [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding), [GO:0097006](http://purl.obolibrary.org/obo/GO_0097006) (regulation of plasma lipoprotein particle levels), [GO:0010897](http://purl.obolibrary.org/obo/GO_0010897) (negative regulation of triglyceride catabolic process), [GO:0016298](http://purl.obolibrary.org/obo/GO_0016298) (lipase activity), [GO:0030301](http://purl.obolibrary.org/obo/GO_0030301) (cholesterol transport), [GO:0070328](http://purl.obolibrary.org/obo/GO_0070328) (triglyceride homeostasis), [GO:0035478](http://purl.obolibrary.org/obo/GO_0035478) (chylomicron binding), [GO:0034383](http://purl.obolibrary.org/obo/GO_0034383) (low-density lipoprotein particle clearance), [GO:0034185](http://purl.obolibrary.org/obo/GO_0034185) (apolipoprotein binding), [GO:0034382](http://purl.obolibrary.org/obo/GO_0034382) (chylomicron remnant clearance), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0043434](http://purl.obolibrary.org/obo/GO_0043434) (response to peptide hormone), [GO:0004622](http://purl.obolibrary.org/obo/GO_0004622) (lysophospholipase activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046470](http://purl.obolibrary.org/obo/GO_0046470) (phosphatidylcholine metabolic process), [GO:0046475](http://purl.obolibrary.org/obo/GO_0046475) (glycerophospholipid catabolic process), [GO:0010989](http://purl.obolibrary.org/obo/GO_0010989) (negative regulation of low-density lipoprotein particle clearance), [GO:0010867](http://purl.obolibrary.org/obo/GO_0010867) (positive regulation of triglyceride biosynthetic process), [GO:0046473](http://purl.obolibrary.org/obo/GO_0046473) (phosphatidic acid metabolic process), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0034379](http://purl.obolibrary.org/obo/GO_0034379) (very-low-density lipoprotein particle assembly), [GO:0010987](http://purl.obolibrary.org/obo/GO_0010987) (negative regulation of high-density lipoprotein particle clearance), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0051259](http://purl.obolibrary.org/obo/GO_0051259) (protein oligomerization), [GO:0034372](http://purl.obolibrary.org/obo/GO_0034372) (very-low-density lipoprotein particle remodeling), [GO:0034371](http://purl.obolibrary.org/obo/GO_0034371) (chylomicron remodeling), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0015012](http://purl.obolibrary.org/obo/GO_0015012) (heparan sulfate proteoglycan biosynthetic process), [GO:0034375](http://purl.obolibrary.org/obo/GO_0034375) (high-density lipoprotein particle remodeling), [GO:0034374](http://purl.obolibrary.org/obo/GO_0034374) (low-density lipoprotein particle remodeling), [GO:0005770](http://purl.obolibrary.org/obo/GO_0005770) (late endosome), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0042953](http://purl.obolibrary.org/obo/GO_0042953) (lipoprotein transport), [GO:0010916](http://purl.obolibrary.org/obo/GO_0010916) (negative regulation of very-low-density lipoprotein particle clearance), [GO:0047372](http://purl.obolibrary.org/obo/GO_0047372) (acylglycerol lipase activity), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0006658](http://purl.obolibrary.org/obo/GO_0006658) (phosphatidylserine metabolic process), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0055102](http://purl.obolibrary.org/obo/GO_0055102) (lipase inhibitor activity), [GO:0034366](http://purl.obolibrary.org/obo/GO_0034366) (spherical high-density lipoprotein particle), [GO:0030169](http://purl.obolibrary.org/obo/GO_0030169) (low-density lipoprotein particle binding), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0034361](http://purl.obolibrary.org/obo/GO_0034361) (very-low-density lipoprotein particle), [GO:0090324](http://purl.obolibrary.org/obo/GO_0090324) (negative regulation of oxidative phosphorylation), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0008970](http://purl.obolibrary.org/obo/GO_0008970) (phosphatidylcholine 1-acylhydrolase activity), [GO:0006633](http://purl.obolibrary.org/obo/GO_0006633) (fatty acid biosynthetic process), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0004806](http://purl.obolibrary.org/obo/GO_0004806) (triglyceride lipase activity), [GO:0070653](http://purl.obolibrary.org/obo/GO_0070653) (high-density lipoprotein particle receptor binding), [GO:0052689](http://purl.obolibrary.org/obo/GO_0052689) (carboxylic ester hydrolase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.73%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) 52.94%
- [GO:0034366](http://purl.obolibrary.org/obo/GO_0034366) (spherical high-density lipoprotein particle) 51.47%
- [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle) 51.47%
- [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle) 51.47%
- [GO:0034361](http://purl.obolibrary.org/obo/GO_0034361) (very-low-density lipoprotein particle) 51.47%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.47%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) 43.14%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0045816](http://purl.obolibrary.org/obo/GO_0045816) (null)) 43.14%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0045811](http://purl.obolibrary.org/obo/GO_0045811) (null)) 43.14%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0045810](http://purl.obolibrary.org/obo/GO_0045810) (null)) 43.14%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0045803](http://purl.obolibrary.org/obo/GO_0045803) (obsolete positive regulation of cytoskeleton)) 43.14%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0045802](http://purl.obolibrary.org/obo/GO_0045802) (obsolete negative regulation of cytoskeleton)) 43.14%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0045791](http://purl.obolibrary.org/obo/GO_0045791) (null)) 43.14%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0045790](http://purl.obolibrary.org/obo/GO_0045790) (null)) 43.14%


